Talnetant | Interleukin Related interleukin-related.com

Product Name :
Talnetant

Search keywords :
Talnetant

drugId :
null

Target Vo:
Neurokinin 3 receptor

Target Vo Short Name :
NK3R

Moa_Name:
Neurokinin 3 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Irritable Bowel Syndrome

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Obiltoxaximab Epigenetic Reader Domain
SREBP1 Rabbit pAb Autophagy
Dynactin Subunit 1 Antibody (YA869): Dynactin Subunit 1 Antibody (YA869) is an unconjugated, approximately 142 kDa, mouse-derived, anti-Dynactin Subunit 1 (YA869) monoclonal antibody. Dynactin Subunit 1 Antibody (YA869) can be used for: WB, IP expriments in human background without labeling.

Author: Interleukin Related

Related Posts